Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: A singleinstitution experience;Radioterapia neoadiuvante associata ad oxaliplatino e 5-fluorouracile in pazienti affetti da tumore rettale localmente avanzato: l'esperienza di un singolo centro

Radiologia Medica

Volumn 118, Issue 4, 2013, Pages 570-582

  Greto, D ^a   Paiar, F ^a   Saieva, C ^b   Galardi, A ^a   Mangoni, M ^a   Livi, L ^a   Agresti, B ^a   Franceschini, D ^a   Bonomo, P ^a   Scotti, V ^a   Detti, B ^a   Tonelli, F ^a   Valeri, A ^a   Messerini, L ^a   Biti, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Scientific Institute of Tuscany   (Italy)

Author keywords

5 Fluorouracil; Chemoradiotherapy; Locally advanced rectal cancer; Oxaliplatin

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; OXALIPLATIN; PLATINUM COMPLEX;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879419226     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0909-4     Document Type: Article

References (17)

1. Ferlay J, Bray F, Sankila R et al (1999) Cancer incidence, mortality and prevalence in the European Union. IARC Press, Lyon
2. Jemal A, Siegel R, Ward E (2009) Cancer statistics. CA Cancer J Clin 59:225-249
3. Jessup JM, Stewart AK, Menck HR et al (1998) The National Cancer Database Report on patterns of care for adenocarcinoma of the rectum 1985-1995. Cancer 83:2408
4. Capirci C, Rampin L, Erba PA et al (2007) Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 34:1583-1593 (Pubitemid 47476915)
5. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative radiochemotherapy for rectal cancer. N Engl J Med 351:1731-1740 (Pubitemid 39383208)
6. Valentini V, Coco C, Cellini N et al (2001) Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 51:371-383 (Pubitemid 32884284)
7. Capirci C, Rubello D, Chierichetti F et al (2006) Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am J Roentgenol 187:W202-W208.7
8. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123 (Pubitemid 44394918)
9. Gérard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620-4625 (Pubitemid 46630960)
10. Ishii Y, Hasegawa H, Endo T et al (2010) Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer. Eur J Surg Oncol 36:1061-1065
11. Wong SJ, Winter K, Meropol NJ et al (2012) Radiation Therapy Oncology Group 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82:1367-1367
12. Belluco C, De Paoli A, Canzonieri V et al (2011) Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol 18:3686-3693
13. de Campos-Lobato LF, Stocchi L, da Luz Moreira A et al (2010) Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers. Ann Surg Oncol 17:1758-1766
14. Dunst J, Debus J, Rudat V et al (2008) Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 184:450-456
15. Koukourakis GV, Zacharias G, Tsalafoutas J et al (2010) Capecitabine for locally advanced and metastatic colorectal cancer: a review. World J Gastrointest Oncol 2:311-321
16. Aschele C, Cionini L, Lonardi S (2011) Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29:2773-2780
17. Gérard JP, Azria D, Gourgou-Bourgade S (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644